The Biosimilars Forum FY2024 filing

Not tax-deductible

Ashburn, VA501(c)(6)Since 2015Community DevelopmentEIN 81-0762544Revenue $2.1M in FY2024

On file with the IRSbiosimilarsforum.org20855 Saber Jet Pl, 20147-6268 · Ashburn, VATax-exempt since Apr 2016

Tell your story. Claim this org

To advance Biosimilars in the united states with the intent of expanding access and availability of biological medicines and improving health care.

Mission: Form 990 Part I, line 1

Before you give

FY2024 · Form 990Independent: from IRS data, not the org
Download 990
IRS status
501(c)(6)
not on the IRS revocation list
Looks good: listed by the IRS and not on the revocation list.
IRS BMF · Auto-Revocation List
Tax-deductible gifts
No
Donations are not tax-deductible
Worth a look: the IRS does not list gifts to it as deductible.
IRS Pub. 78 · IRS BMF
Latest return
FY2025
latest Form 990
Looks good: the latest return is for FY2025, 1 tax year back; within 2 tax years.
IRS e-file · Filing history
Surplus or deficit
3 of 6
filings with a surplus
Average deficit $18K a year · under 1% of revenue · last 6 filings
Worth a look: a surplus in 3 of the last 6 filings.
Pt I · Ln 19 · 6 filings
Spent on programs
0%
of spending
Concern: 0% of spending went to programs; under 50%.
Pt IX · Ln 25 · col B
Cash reserves
3 mo
of spending, in cash
Looks good: 3.2 months of spending in cash; 3 or more.
Pt X · Ln 1–2 · Pt I · Ln 18
Liabilities
$2.3M
86% of total assets
Concern: liabilities are 86% of assets; over 80%.
Pt X · Ln 26
Independent board members
9
of 9 voting members
Looks good: 9 of 9 voting members are independent, a majority.
Pt VI · Ln 1a–1b
Looks goodFineWorth a lookConcernNo data yetTap a box for the reason.
Revenue
$2.1M
-7% vs prior year
Spent
$2.0M
To programs
0%
Net assets
$375K
By yearFY2020–FY2025
Revenue
$2.1M
FY2024▼ -7%
Tap a bar for its year
Revenue by fiscal year
FY2020$2.2M
FY2021$2.1M
FY2022$2.1M
FY2023$2.3M
FY2024$2.1M
FY2025$2.3M
Expenses
$2.0M
FY2024▼ -19%
Tap a bar for its year
Expenses by fiscal year
FY2020$2.0M
FY2021$2.3M
FY2022$2.4M
FY2023$2.4M
FY2024$2.0M
FY2025$2.2M
Net assets
$375K
FY2024▲ +57%
Tap a bar for its year
Net assets by fiscal year
FY2020$899K
FY2021$703K
FY2022$388K
FY2023$238K
FY2024$375K
FY2025$505K

From the FY2024 Form 990 · figures checked against the IRS filing · see the original

Give Claim
You’re viewing the FY2024 filing — not the latest on file. See the latest (FY2025) →

Is it real?

Yes. Never revoked by the IRS. Latest filing on record: FY2025. IRS ruling in Apr 2016.

IRS Pub. 78 · IRS Auto-Revocation List · IRS Business Master File

Who runs it and what they're paid

10 people listed on the 990.

Part VII, Section A · reportable compensation
Executive Di
$0Pt VII · Sec A
Treasurer &
$0Pt VII · Sec A
$0Pt VII · Sec A
Director (ex
$0Pt VII · Sec A
Director
$0Pt VII · Sec A
$0Pt VII · Sec A
$0Pt VII · Sec A
$0Pt VII · Sec A
See The Biosimilars Forum executive salaries →

On this list? Claim this org

Something off? Claim to fix it

Questions the 990 asks

The form asks each of these directly. These are the filed answers.

  • Family or business ties among officersPt VI · Ln 2No
  • Top official's pay set by an independent reviewPt VI · Ln 15aNo

Programs and updates

Promotes biosimilars to expand access to biological medicines and improve healthcare.

Questions for The Biosimilars Forum

Tap to ask. The Biosimilars Forum sees how many people are interested.

Your first name shows with your question. The Biosimilars Forum answers here, for everyone.

Provided by the organization

Know this org? Add your story

3 programs · in their own filed words · FY2024
01

The biosimilars forum provides evidence-based information to inform and support public policies that encourage awareness, access, and adoption of biosimilars.

Pt IX · col B
02

The biosimilars forum supports the education of health care providers and patients on the fda approval of biosimilars and safety of biosimilars.

Pt IX · col B
03

The biosimilars forum works with third party stakeholders to advance policies that support patient access to lower cost biosimilars.

Pt IX · col B

By the numbers

The FY2024 990, line by line.

1The main four
Money inPt VIII
$2.1M
Ln 12
Gifts and grantsLn 1h$2.1M
Money outPt IX
$2.0M
Ln 25
Owns and owesPt X
$375K
net assets · Ln 32
Cash and savingsLn 1–2$523K
Total assetsLn 16$2.7M
LiabilitiesLn 26$2.3M
PeoplePt VI, VII
10
listed · VII A
PaidVII A0
Voting boardVI 1a9
IndependentVI 1b9
2In more detail
Revenue in detailPt VIII
Gifts and grantsLn 1h$2.1M
Total revenueLn 12$2.1M
Assets in detailPt X, end of year
CashLn 1$523K
Cash and savings togetherLn 1–2$523K
Total assetsLn 16$2.7M
LiabilitiesLn 26$2.3M
Net assetsLn 32$375K
OperationsPt I, VI
EmployeesI 50
VolunteersI 68
Fiscal year endsHeaderDecember
Conflict-of-interest policyVI 12aNo
Whistleblower policyVI 13No
Records policyVI 14No
3Year over year
Balance sheet, start vs end of yearPt X · col A, B
LineStart FY24End FY24
Cash and savingsLn 1–2$661K$523K
Total assetsLn 16$2.5M$2.7M
LiabilitiesLn 26$2.2M$2.3M
Net assetsLn 32$238K$375K
4Every line
Statement of functional expensesPt IX · every line
LineTotalProgramsManagementFundraising
Management feesLn 11a$415K
Accounting feesLn 11c$15K
Lobbying feesLn 11d$358K
Other fees for servicesLn 11g$877K
Office expensesLn 13$13K
TravelLn 17$38K
Conferences, conventions and meetingsLn 19$228K
InsuranceLn 23$3K
Other expenses (24a–d)Ln 24$35K
Total functional expensesLn 25$2.0M$0$0$0

Filing history

YearMoney inMoney outIn minus outNet assetsDownload
FY2025 Latest $2.3M$2.2M$130K$505K 990 PDF
FY2024 Viewing $2.1M$2.0M$137K$375K 990 PDF
FY2023 $2.3M$2.4M−$150K$238K 990 PDF
FY2022 $2.1M$2.4M−$314K$388K 990 PDF
FY2021 $2.1M$2.3M−$197K$703K 990 PDF
FY2020 $2.2M$2.0M$290K$899K 990 PDF

More to add? Claim this org

Schedules filed Part IV

III · Programs I · Grants R · Related orgs G · Fundraising L · Interested persons A · Public support F · Foreign M · Noncash
See the full FY2024 990 (6 parts)
Part I · Summary $2,117,500 revenue, 12 lines filed
I-8 Contributions and grantsPrior year $2,280,500$2,117,500
I-9 Program service revenue$0
I-10 Investment income$0
I-11 Other revenue$0
I-12 Total revenuePrior year $2,280,500$2,117,500
I-13 Grants and similar amounts paid$0
I-14 Benefits paid to members$0
I-15 Salaries and benefits$0
I-16a Professional fundraising fees$0
I-17 Other expensesPrior year $2,430,491$1,980,827
I-18 Total expensesPrior year $2,430,491$1,980,827
I-19 Revenue less expensesPrior year −$149,991$136,673
Part VI · Governance 9 of 9 board members independent, 4 to look at
VI-1a Voting members of the governing body9
VI-1b Independent voting members9
VI-12a Written conflict of interest policyNo
VI-13 Written whistleblower policyNo
VI-14 Document retention and destruction policyNo
VI-15a Process for setting top official's payNo
VI-2 Family or business relationship among officers or directorsNo
Part VIII · Statement of revenue $2,117,500 across 3 lines filed
VIII-1b Membership dues$2,117,500
VIII-1h Total contributions, gifts and grants$2,117,500
VIII-12 Total revenue$2,117,500
Part IX · Statement of functional expenses $1,980,827 across 9 lines filed
IX-11a Management fees$414,996
IX-11c Accounting fees$15,000
IX-11d Lobbying fees$357,500
IX-11g Other fees for services$876,795
IX-13 Office expenses$12,798
IX-17 Travel$38,073
IX-19 Conferences, conventions and meetings$228,075
IX-23 Insurance$2,590
IX-24 Other expenses (24a–d)$35,000
IX-25 Total functional expensesPrograms $0 · Management $0 · Fundraising $0$1,980,827
Part X · Balance sheet $2,722,624 assets, 9 lines filed
X-1 Cash, non-interest-bearingStart of year $660,951$522,624
X-4 Accounts receivableStart of year $1,797,500$2,200,000
X-16 Total assetsStart of year $2,473,451$2,722,624
X-17 Accounts payable and accrued expensesStart of year $72,505$10,005
X-19 Deferred revenueStart of year $2,162,500$2,337,500
X-26 Total liabilitiesStart of year $2,235,005$2,347,505
X-27 Net assets without donor restrictionsStart of year $238,446$375,119
X-32 Total net assets or fund balancesStart of year $238,446$375,119
X-33 Total liabilities and net assetsStart of year $2,473,451$2,722,624
Part XI · Reconciliation of net assets $375,119 net assets at year end
XI-1 Total revenue$2,117,500
XI-2 Total expenses$1,980,827
XI-3 Revenue less expenses$136,673
XI-4 Net assets at start of year$238,446
XI-10 Net assets at end of year$375,119

Form 990 e-file (XML) FY2024 from the IRS · Classification, formation year and address from the IRS Business Master File

Similar organizations you could support · Compare with another nonprofit

Names, privacy, and removal requests More

The names, titles, and compensation shown on this page are reproduced from IRS Form 990 filings, which are public records.

Philanthropy.org does not alter the content of those filings. All information appears exactly as reported by the filing organization for the tax year shown.

We publish only information contained in the public IRS filing — and less than the filing contains. Our profile pages do not display street addresses, telephone numbers, personal email addresses, or other personal contact information, even where the filing includes them.

Many people share the same name. A name shown on this page reflects only what one organization reported in one IRS filing for one tax year. It should not be interpreted as identifying any other individual with the same or a similar name.

If you are no longer affiliated with the organization, your name will generally stop appearing in future IRS filings once the organization no longer reports you. Pages for tax years in which you were reported remain published because those filings remain part of the public record.

Philanthropy.org does not alter or remove IRS filing records. Removing a page from this website would not remove the underlying IRS filing, which remains publicly available from the IRS and other publishers of the same information.

If you believe the IRS filing itself is inaccurate, corrections must be made by the filing organization or the IRS directly.

Your org? Add context

Made it to the end? Claim this org

All figures are derived from public IRS Form 990 filings and are presented without evaluation of any organization. philanthropy.org does not rate, score, or rank organizations, including the pay comparisons above.